These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9247609)

  • 21. Involvement of up-regulation of hepatic breast cancer resistance protein in decreased plasma concentration of 7-ethyl-10-hydroxycamptothecin (SN-38) by coadministration of S-1 in rats.
    Yokoo K; Hamada A; Watanabe H; Matsuzaki T; Imai T; Fujimoto H; Masa K; Imai T; Saito H
    Drug Metab Dispos; 2007 Sep; 35(9):1511-7. PubMed ID: 17537871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of beta-glucuronidase in intestinal microflora in the intestinal toxicity of the antitumor camptothecin derivative irinotecan hydrochloride (CPT-11) in rats.
    Takasuna K; Hagiwara T; Hirohashi M; Kato M; Nomura M; Nagai E; Yokoi T; Kamataki T
    Cancer Res; 1996 Aug; 56(16):3752-7. PubMed ID: 8706020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Irinotecan (CPT-11) and characteristic mucosal changes in the mouse ileum and cecum.
    Ikuno N; Soda H; Watanabe M; Oka M
    J Natl Cancer Inst; 1995 Dec; 87(24):1876-83. PubMed ID: 7494232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea.
    Takasuna K; Hagiwara T; Watanabe K; Onose S; Yoshida S; Kumazawa E; Nagai E; Kamataki T
    Cancer Chemother Pharmacol; 2006 Oct; 58(4):494-503. PubMed ID: 16437251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacokinetics of SN-38 in rats and tissue distribution of 7-ethyl-10-hydroxycamptothecin in mice after intravenous injection of irinotecan hydrochloride nanoparticles].
    Yang FY; Zhang WP; Wang XY; Yang WC; Dang HW
    Yao Xue Xue Bao; 2014 Jul; 49(7):1029-33. PubMed ID: 25233635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curcumin protects heart tissue against irinotecan-induced damage in terms of cytokine level alterations, oxidative stress, and histological damage in rats.
    Ciftci O; Turkmen NB; Taslıdere A
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Aug; 391(8):783-791. PubMed ID: 29721577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reactivity of plasma glutathione peroxidase with hydroperoxide substrates and glutathione.
    Esworthy RS; Chu FF; Geiger P; Girotti AW; Doroshow JH
    Arch Biochem Biophys; 1993 Nov; 307(1):29-34. PubMed ID: 8239661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Difference in effects of classic and phospholipid hydroperoxide glutathione peroxidases on liver lipid peroxide level in selenium-deficient rats.
    Guan JY; Komura S; Ohishi N; Yagi K
    Biochem Mol Biol Int; 1995 Dec; 37(6):1103-10. PubMed ID: 8747540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between development of diarrhea and the concentration of SN-38, an active metabolite of CPT-11, in the intestine and the blood plasma of athymic mice following intraperitoneal administration of CPT-11.
    Araki E; Ishikawa M; Iigo M; Koide T; Itabashi M; Hoshi A
    Jpn J Cancer Res; 1993 Jun; 84(6):697-702. PubMed ID: 8340259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preventive effect of naringin on lipid peroxides and antioxidants in isoproterenol-induced cardiotoxicity in Wistar rats: biochemical and histopathological evidences.
    Rajadurai M; Stanely Mainzen Prince P
    Toxicology; 2006 Dec; 228(2-3):259-68. PubMed ID: 17084010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacokinetics and tissue distribution of irinotecan hydrochloride nanoparticles].
    Yang FY; Zhang WP; Chen HL; Fu Y; Wang XY; Wei SJ; Yang XY; Zhang YX; Dang HW
    Yao Xue Xue Bao; 2013 Jun; 48(6):940-5. PubMed ID: 23984532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antitumor effect of DX-8951, a novel camptothecin analog, on human pancreatic tumor cells and their CPT-11-resistant variants cultured in vitro and xenografted into nude mice.
    Takiguchi S; Kumazawa E; Shimazoe T; Tohgo A; Kono A
    Jpn J Cancer Res; 1997 Aug; 88(8):760-9. PubMed ID: 9330608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of UDP-glucuronosyltransferase activity in irinotecan-induced delayed-onset diarrhea in rats.
    Onoue M; Kurita A; Kado S; Matsumoto T; Kaneda N; Uchida K; Kato I; Yokokura T
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):595-605. PubMed ID: 17549477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of doxorubicin on lipid peroxide levels in tissues of mice.
    Sazuka Y; Yoshikawa K; Tanizawa H; Takino Y
    Jpn J Cancer Res; 1987 Nov; 78(11):1281-6. PubMed ID: 3121563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of orpiment (As2S3) on cytochrome P-450, glutathione and lipid peroxide levels of rat liver.
    Singh P; Sharma R
    J Environ Pathol Toxicol Oncol; 1994; 13(3):199-203. PubMed ID: 7536845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modified irinotecan hydrochloride (CPT-11) administration schedule improves induction of delayed-onset diarrhea in rats.
    Kurita A; Kado S; Kaneda N; Onoue M; Hashimoto S; Yokokura T
    Cancer Chemother Pharmacol; 2000; 46(3):211-20. PubMed ID: 11021738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel irinotecan-loaded liposome using phytic acid with high therapeutic efficacy for colon tumors.
    Hattori Y; Shi L; Ding W; Koga K; Kawano K; Hakoshima M; Maitani Y
    J Control Release; 2009 May; 136(1):30-7. PubMed ID: 19331859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Camptothecin analogues with enhanced antitumor activity at acidic pH.
    Adams DJ; Dewhirst MW; Flowers JL; Gamcsik MP; Colvin OM; Manikumar G; Wani MC; Wall ME
    Cancer Chemother Pharmacol; 2000; 46(4):263-71. PubMed ID: 11052623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell cycle-dependent chronotoxicity of irinotecan hydrochloride in mice.
    Ohdo S; Makinosumi T; Ishizaki T; Yukawa E; Higuchi S; Nakano S; Ogawa N
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1383-8. PubMed ID: 9400014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Optimal dosing schedule in combination therapy with irinotecan and doxifluridine in a human colorectal cancer xenograft model].
    Yanagisawa M; Ishikawa T; Ouchi KF; Tanaka Y
    Gan To Kagaku Ryoho; 2003 Feb; 30(2):223-30. PubMed ID: 12610870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.